Category: Forbes

AI, Health, And The Future Of Human Agency

How machine learning will disrupt medicine – but why we need decision making to remain with the patient. Ashoka talks with Dr. Stephen Friend.

Angry Your Doctor Won’t Tell You What That Test Costs? You Should Be!

I’m angry about the way our healthcare system has been shifting costs to patients, often without informing them in advance. I am determined to help rein in the costs of American medical care and want to spread stories of people who have had first-hand …

How To Choose The Right Tech Vendor: 13 Strategies For Small Businesses

Choosing the right vendor for your company’s software needs can be tricky, especially as a small business. Consider the following before hiring your next tech vendor.

Novartis Delayed Reveal Of Bad Data For $2.1 Million Gene Therapy. Now Patients And Pharma Suffer.

Narasimhan’s poor decision making has had negative consequences not just for Novartis but also for the industry and patients. Let’s hope it’s not repeated.

Juul Raises $325 Million For International Expansion

The funding comes as Juul faces opposition from lawmakers in the U.S.

Planned Parenthood Rejects Title X Funding, Because Of Trump Abortion Gag Rule

Rule restricts clinics’ ability to give abortion referrals.

Boom in Cosmetic Surgery Linked to Age Discrimination

A significant number of adults undergo cosmetic procedures after experiencing age discrimination or because they fear age discrimination.

New Survey Shows Many People Think Their Doctors Should Refuse To See Unvaccinated Children

Three out of ten people think that parents of unvaccinated children should be asked to find a new doctor, according to a new survey of over 2,000 American parents.

Are We Nearing The End Of Medicare’s Three-Day Rule That Makes Patients Pay For Skilled Nursing Care?

Is Medicare’s dreaded three-day rule coming to an end?

Explaining Medicare Part D’s Success As A Byproduct Of Flat Voucher Subsidies

Medicare Part D is considered by many policymakers as a role model for publicly financed, privately provided social insurance programs. Medicare Part D’s structure keeps subsidies in check by virtue of its flat voucher subsidy design.